Halozyme Therapeuticsincis A Biotechnology Company Based In San Diegocaliforniafounded In 1998The Company Specializes In Developing And Commercializing Recombinant Human Enzymes Aimed At Improving The Delivery Of Biologics And Drugshalozyme S Mission Is To Enhance Patient Experiences And Outcomes Through Innovative Solutions The Primary Product Offered By Halozyme Is Hylenexa Recombinant Formulation That Facilitates Subcutaneous Fluid Administrationimproving Hydration And Drug Absorptionthe Company Also Features The Enhanze Drug Delivery Technologywhich Utilizes Its Patented Recombinant Human Hyaluronidase Enzymerhuph20This Technology Is Employed In Partnerships With Major Pharmaceutical Companiesincluding Pfizerrocheand Janssento Advance Cancer Treatmentsadditionallyhylenex Is Distributed In Collaboration With Baxterhalozyme S Internal Team Has Expertise In Developing Auto Injector Devices And Custom Solutionsreflecting The Company S Commitment To Generating Value For Patients And Shareholders
